Document is current
Any future updates will be listed below
-
Authors
Seman, Zahidah Abu
Ahid, Fadly http://orcid.org/0000-0002-1953-4593
Kamaluddin, Nor Rizan
Sahid, Ermi Neiza Mohd
Esa, Ezalia
Said, Siti Shahrum Muhamed
Azman, Norazlina
Mat, Wan Khairull Dhalila Wan
Abdullah, Julia
Ali, Nurul Aqilah
Khalid, Mohd Khairul Nizam Mohd
Yusoff, Yuslina Mat
-
Funding
Funding for this research was provided by:
Kementerian Kesihatan Malaysia
UiTM MyRA Research Grant
- License Information
-
More Information
Article History
Received: 5 July 2023
Accepted: 15 April 2024
First Online: 20 April 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Medical Research and Ethics Committee (MREC), Ministry of Health, Malaysia [(NMRR-19-3693-52311) (Ref. no. KKM/NIHSEC/P20-186(6); date approval 3/2/2020)]. The RNA sample utilised in the present research was sourced from the Pathology Laboratory at Hospital Tunku Azizah and Diagnostic Laboratory Haematology at Institute for Medical Research (IMR), National Institute of Health (NIH). The samples were used in routine lab tests for detection and quantification of <i>BCR::ABL1</i> transcripts and <i>BCR::ABL1</i> mutation detection and would be discarded if not used for research purposes. Patients’ medical records were accessed from January 2017 to December 2020. The investigator recorded the information in a way that ensures subjects cannot be identified either directly or indirectly through associated identifiers. Both the archival of medical records and study data will be deleted upon completion of the research. Therefore, the informed consent was waived by the MREC committee that reviewed the entire study protocol.
: Not applicable.
: The authors declare no competing interests.
